Skip to main content
ConductScienceScienceDex

Douglas M McCarty

NIH Rank #1952
Unclaimed recordClaim profile
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6409365Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$4.1M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#1,952
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Douglas M McCarty. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Douglas M McCarty as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS143501-01R44
    Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I
    Neurogt, Inc.
    $1.5M
    award amount
  • 4R44NS135667-02R44
    Development of gene therapy product for treating MPS IIIB
    Neurogt, Inc.
    $1.3M
    award amount
  • 5R44AI172670-03R44
    Protein depleting pre-existing antibodies for viral gene therapy
    Neurogt, Inc.
    $969.8K
    award amount
  • 1R41NS143578-01R41
    Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC
    Neurogt, Inc.
    $349.9K
    award amount

Award organization

Organizations that administered FY2025 awards listing Douglas M McCarty as a PI.

FY2025 award administered by Neurogt, Inc. (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Neurogt, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9033
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #1952
  8. 2025
    Entered Top 10% Nationally
    Ranked #1952

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Douglas M McCarty.

Haiyan Fu
Neurogt, Inc.
2
shared awards

Explore further

Find collaborators for Douglas M McCarty

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →